National Institutes of Health Consensus Development Conference: Management of hepatitis C: 2002

被引：180
作者：
Seeff, LB [1 ]
Hoofnagle, JH [1 ]
机构：
[1] NIDDKD, Div Digest Dis & Nutr, NIH, Bethesda, MD 20892 USA
来源：
HEPATOLOGY | 2002年 / 36卷 / 05期
关键词：
D O I：
10.1053/jhep.2002.36992
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S1 / S2
页数：2
相关论文
共 5 条
  • [1] The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
    Alter, MJ
    Kruszon-Moran, D
    Nainan, OV
    McQuillan, GM
    Gao, FX
    Moyer, LA
    Kaslow, RA
    Margolis, HS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) : 556 - 562
  • [2] The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
    Armstrong, GL
    Alter, MJ
    McQuillan, GM
    Margolis, HS
    [J]. HEPATOLOGY, 2000, 31 (03) : 777 - 782
  • [3] Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296
  • [4] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
    Manns, MP
    McHutchison, JG
    Gordon, SC
    Rustgi, VK
    Shiffman, M
    Reindollar, R
    Goodman, ZD
    Koury, K
    Ling, MH
    Albrecht, JK
    [J]. LANCET, 2001, 358 (9286) : 958 - 965
  • [5] *NAT I HLTH CONS D, 1997, HEPATOLOGY S1, V26, pS1
1